VEGFA and neoplasm: Here came the idea of combining CPI with anti-VEGF therapy to promote vascular normalization, where the immunosuppressive niche of the TME can be transformed into an immune stimulatory media supporting the entrance of the immune effector cells and their accumulation, leading to an enhanced anti-tumor activity by promoting hypoxia and inhibiting the function of the suppressive cells (Figure 2) (189).